X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with ALEMBIC LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ALEMBIC LTD - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER ALEMBIC LTD PFIZER/
ALEMBIC LTD
 
P/E (TTM) x 24.2 74.8 32.3% View Chart
P/BV x 3.8 2.8 138.4% View Chart
Dividend Yield % 0.8 0.4 208.7%  

Financials

 PFIZER   ALEMBIC LTD
EQUITY SHARE DATA
    PFIZER
Mar-16
ALEMBIC LTD
Mar-16
PFIZER/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs2,72453 5,159.1%   
Low Rs1,61129 5,498.3%   
Sales per share (Unadj.) Rs440.94.7 9,341.2%  
Earnings per share (Unadj.) Rs48.78.8 555.0%  
Cash flow per share (Unadj.) Rs75.89.0 841.6%  
Dividends per share (Unadj.) Rs15.000.15 10,000.0%  
Dividend yield (eoy) %0.70.4 189.4%  
Book value per share (Unadj.) Rs462.927.7 1,669.7%  
Shares outstanding (eoy) m45.75267.03 17.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.98.7 56.5%   
Avg P/E ratio x44.54.7 951.4%  
P/CF ratio (eoy) x28.64.6 627.4%  
Price / Book Value ratio x4.71.5 316.2%  
Dividend payout %30.81.7 1,801.8%   
Avg Mkt Cap Rs m99,16310,962 904.6%   
No. of employees `0002.9NA-   
Total wages/salary Rs m2,758238 1,158.6%   
Avg. sales/employee Rs Th6,981.7NM-  
Avg. wages/employee Rs Th954.5NM-  
Avg. net profit/employee Rs Th771.1NM-  
INCOME DATA
Net Sales Rs m20,1701,260 1,600.4%  
Other income Rs m857264 325.0%   
Total revenues Rs m21,0281,524 1,379.7%   
Gross profit Rs m4,31083 5,205.1%  
Depreciation Rs m1,23961 2,017.4%   
Interest Rs m50 1,733.3%   
Profit before tax Rs m3,923285 1,377.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m02,096 0.0%   
Extraordinary Inc (Exp) Rs m99-32 -307.0%   
Tax Rs m1,7946 29,416.4%   
Profit after tax Rs m2,2282,343 95.1%  
Gross profit margin %21.46.6 325.2%  
Effective tax rate %45.72.1 2,136.1%   
Net profit margin %11.0185.9 5.9%  
BALANCE SHEET DATA
Current assets Rs m16,2991,689 965.1%   
Current liabilities Rs m7,594486 1,561.8%   
Net working cap to sales %43.295.4 45.2%  
Current ratio x2.13.5 61.8%  
Inventory Days Days65217 30.1%  
Debtors Days Days2681 31.8%  
Net fixed assets Rs m8,6221,624 530.9%   
Share capital Rs m458534 85.7%   
"Free" reserves Rs m20,7225,960 347.7%   
Net worth Rs m21,1807,404 286.1%   
Long term debt Rs m25104 24.0%   
Total assets Rs m29,1378,010 363.7%  
Interest coverage x755.5950.7 79.5%   
Debt to equity ratio x00 8.4%  
Sales to assets ratio x0.70.2 440.0%   
Return on assets %7.729.3 26.2%  
Return on equity %10.531.6 33.2%  
Return on capital %19.031.3 60.7%  
Exports to sales %0.12.9 2.0%   
Imports to sales %17.528.9 60.6%   
Exports (fob) Rs m1237 32.3%   
Imports (cif) Rs m3,526364 969.4%   
Fx inflow Rs m5237 139.2%   
Fx outflow Rs m140365 38.4%   
Net fx Rs m-88-328 26.9%   
CASH FLOW
From Operations Rs m3,436346 994.3%  
From Investments Rs m-6,991-48 14,686.8%  
From Financial Activity Rs m-619-301 205.6%  
Net Cashflow Rs m-4,174-3 139,116.7%  

Share Holding

Indian Promoters % 0.0 64.0 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 0.2 3,750.0%  
FIIs % 4.9 9.7 50.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 26.1 90.8%  
Shareholders   85,207 54,701 155.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   CADILA HEALTHCARE  TTK HEALTHCARE  ORCHID PHARMA LTD  DISHMAN PHARMA  J.B.CHEMICALS  

Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Vishal Sikka's Infosys Exit, White House Shake up & Cues to Watch Out Today(Pre-Open)

Indian share markets ended lower on Friday but gained during the overall week. At the closing bell on Friday, BSE Sensex closed lower by 271 points and the NSE Nifty finished down 67 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Aug 18, 2017 (Close)

TRACK PFIZER

PFIZER - STRIDES SHASUN LTD COMPARISON

COMPARE PFIZER WITH

MARKET STATS